Advertisement
Screener

Kiniksa Pharmaceuticals International, plc (KNSA) Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months

Kiniksa Pharmaceuticals International, plc Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months

Kiniksa Pharmaceuticals International, plc (KNSA) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months of $0 as of 2024-03-31, per its 10-Q filed 2024-04-25.

Discontinued › Notes

us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months · last filed 2024-04-25

  • 2024-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $0.00.
  • 2023-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $0.00.
  • 2023-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $0.00.
  • 2023-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $0.00.
Period endDebt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 MonthsDebt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months as first filed
2024-03-31$0.00
10-Q · filed 2024-04-25
2023-12-31$0.00
10-K · filed 2024-02-28
2023-09-30$0.00
10-Q · filed 2023-11-02
2023-06-30$0.00
10-Q · filed 2023-08-01
2023-03-31$0.00
10-Q · filed 2024-04-25
2022-12-31$7.47M
10-K · filed 2023-03-02
2022-09-30$0.00
10-Q · filed 2023-11-02
$22.47M
10-Q · filed 2022-11-03
2022-06-30$0.00
10-Q · filed 2023-08-01
$43.90M
10-Q · filed 2022-08-04
2022-03-31$0.00
10-Q · filed 2023-05-04
$82.25M
10-Q · filed 2022-05-05
2021-12-31$49.74M
10-K · filed 2023-03-02
2021-06-30$34.10M
10-Q · filed 2021-08-05
2021-03-31$29.00M
10-Q · filed 2021-05-06
2020-12-31$107.75M
10-K · filed 2022-02-24
2020-09-30$78.06M
10-Q · filed 2020-11-05
2020-06-30$113.68M
10-Q · filed 2020-08-04
2019-12-31$43.11M
10-K · filed 2021-02-25